GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [PSA] hypoglycaemia is not what most of this community thinks it is — 30 comments in the full submission. View in context.
867
c/t2dglp1·submitted 1 months ago by u/nadia_norgaard

[PSA] hypoglycaemia is not what most of this community thinks it is

Resultsbranch of 6 comments

Writing this once so it can be linked instead of retyped: hypoglycaemia is not what most of this community thinks it is. Assumed the weight endpoints from the obesity trials applied to my situation. They are different programmes. Variability dropped before the average did, which was visible on the sensor and…

Read the full submission and all 30 comments →

This branch

6 comments, started 1 months ago
u/arne_amankwah13 points·1 months ago·edited

Continuous monitoring shows the shape: postprandial excursions, overnight behaviour and time in range. Two people with identical A1c can have very different distributions.

replysharereportpermalink
u/niels_salinas4 points·1 months ago

check the trial population before quoting a result at somebody

replysharereportpermalink
u/georgi_haddad8 points·1 months ago

Sensor accuracy varies across wear, and readings on the first day are the least reliable. Calibration practice and compression artefacts explain many alarming single values.

replysharereportpermalink
u/kaia_cabrera4 points·1 months ago

Correcting myself: 18 weeks between those two A1c results, which is too short an interval to interpret.

replysharereportpermalink
u/lyophile_lou1 point·1 months ago

Have you taken this to whoever manages your diabetes?

replysharereportpermalink
u/yannick_barros1 point·1 months ago

Yes — the person managing your diabetes is the one to talk to, and this board is explicit about that.

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/t2dglp1
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/a1c_arcu/fasting_insulin_fu/gentle_correction
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →